Peer-reviewed veterinary case report
Dog with chronic diarrhea improved by oral fecal transplant treatment
By Cerquetella M et al.·2022·School of Biosciences and Veterinary Medicine, Italy·View original on Europe PMC →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Case Report: Oral Fecal Microbiota Transplantation in a Dog Suffering From Relapsing Chronic Diarrhea-Clinical Outcome and Follow-Up.
- Species:
- dog
Plain-English summary
A dog with relapsing chronic diarrhea was treated with fecal microbiota transplantation (FMT) using frozen capsules, as he needed a low dose of steroids to manage his symptoms. After the treatment, his diarrhea improved significantly, and other issues like bloating and painful defecation also got better. Over an 18-month follow-up, the dog did not experience any serious relapses and did not need an increase in his steroid medication. This treatment appeared to be effective without any reported side effects.
People also search for: dog chronic diarrhea treatment · fecal microbiota transplant for dogs · dog inflammatory bowel disease management
Abstract
The present case report describes the effects of orally administered fecal microbiota transplantation (FMT) (frozen capsules) in a dog suffering from relapsing chronic diarrhea, needing a continuous low prednisolone dose to maintain the condition under acceptable control. Through FMT, we aimed at evaluating the possibility of improving the clinical score and/or reducing/suspending steroid administration. During a first period of strict monitoring (21 days), the canine inflammatory bowel disease activity index (CIBDAI) score passed from mild to clinically insignificant disease. Furthermore, two additional gastrointestinal signs that had been reported, bloating and episodes of painful defecation, rapidly improved (bloating) or even resolved (painful defecation). The patient was then followed for 18 months (to the authors' knowledge, the longest follow-up time ever reported in a dog), during which no serious relapses occurred and no increase in prednisolone dose was necessary. No adverse clinical effects were ever reported during monitoring. The present description provides a further experience increasing those already present in the veterinary literature, in which an agreement on how to use FMT has not yet been achieved although strongly needed and recommended.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Europe PMC: https://europepmc.org/article/MED/35859811